Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO Support
Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO Support
Recruiting · NCT06442267 · Registry updated 2024-10-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO Support | Embolism and Thrombosis, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Shock, Thromboembolism, cardiovascular disorder, respiratory failure, respiratory system disorder, vascular disorder | Recruiting | Phase 4 | 2024-10-29 | NCT06442267 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Medical University of Vienna | 195 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Medical University of Vienna | Vienna | Austria | 29 |